BSE filing, BSE: 543346. Summary written from the filing by ALFA Finder's alert engine.
Aashka Hospitals Ltd: key numbers
- Share price
- ₹96.90
- Market cap
- ₹226.8 Cr
- Revenue (annual)
- ₹23.01 Cr
- Net profit (annual)
- ₹3.34 Cr
- P/E (TTM)
- 67.9×Sector 53.8×
- Promoter holding
- 61.34%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aashka Hospitals Ltd
All →Aashka Hospitals Board Meeting Date
Aashka Hospitals Ltd informed BSE of a board meeting on 05 November 2026 to consider unaudited standalone financial results for the half year ended September 30, 2026. The filing is a routine board meeting intimation.
Koura Fine Diamond Jewelry H1 FY27 Results: Net Profit ₹3.1 Cr, Up 675.0% YoY
Koura Fine Diamond Jewelry Ltd reported revenue from operations of ₹63.8 Cr (+6.3% YoY) and net profit of ₹3.1 Cr (+675.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹3.1 Cr · +675.0% YoY
Aashka Hospitals Price Movement Clarification
Aashka Hospitals clarified that the recent significant movement in its share price is purely market-driven. The company is unaware of any specific reason for this movement.
Aashka Hospitals Annual General Meeting
Aashka Hospitals Ltd held its 14th Annual General Meeting on 24 September 2026. The meeting transacted ordinary and special business resolutions as per the notice.
Aashka Hospitals Annual Report
Aashka Hospitals has submitted its Annual Report for the financial year 2025-26, pursuant to Regulation 34 of the SEBI LODR Regulations.
Aashka Hospitals Annual General Meeting
Aashka Hospitals Ltd has issued a notice for its 14th Annual General Meeting scheduled for September 24, 2026. Shareholders will consider accounts and special resolutions.
Other debt & borrowing announcements
All →Max Estates Debt & Borrowing: ₹350 Cr
Max Estates' board approved a ₹350 crore corporate guarantee for a wholly-owned subsidiary's term loan. Monitoring agency reports on its QIP and warrant proceeds were also filed.
- Value
- ₹350.0 Cr
Credent Connect N Care Debt & Borrowing: ₹4.5 Cr
Credent Connect N Care's board approved an unsecured inter-corporate loan of Rs 4.50 Crore to Kartavya Healtheon Private Limited. The loan carries 12% compounded interest after 25 November 2026 and gives the lender a right to up to 26% equity.
- Value
- ₹4.50 Cr
Amines & Plasticizers Debt & Borrowing
Amines & Plasticizers invited members to place unsecured deposits under Form DPT-1. Only resident members may subscribe, and the scheme is on the company website.
HEG Advanced Materials Debt & Borrowing: ₹50 Cr
HEG granted subsidiary Replus Engitech an unsecured revolving loan of Rs.50 Crore. It is repayable on demand at 9% interest, at arm's length.
- Value
- ₹50.00 Cr
- Execution
- Repayable on demand
Purple Finance Debt & Borrowing: ₹25 Cr
Purple Finance's finance committee approved issuing up to 25,000 senior secured NCDs aggregating ₹25 Crore on a private placement basis. The debentures carry an 11.50% coupon and a 30-month tenure.
- Value
- ₹25.00 Cr
- Execution
- 30 months from deemed date of allotment
Bloom Industries Debt & Borrowing: ₹113 Cr
Bloom Industries approved pledging 9.40% of Shivom Minerals shares to secure ₹113 Crore NCDs and convened an EGM. The company states no material adverse operational impact.
- Value
- ₹113.0 Cr